Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical
RARE | NASDAQ
Chart Builder DCF Calculator
$15.90
-$0.18 (-1.12%)
At close: Nov 16, 2026, 4:00 PM ET
$15.85
-$0.05 (-0.31%)
After-hours: Nov 16, 2026, 7:30 PM ET

Ultragenyx Pharmaceutical Insider Trading

Insider trading explained
90-Day Net Volume
-$127.56K
90-Day Activity
0 Buys / 3 Sales
All-Time Net Volume
-$95.83M
Total Filings
987

Insider Trading Activity

Name Transaction Date Transaction Type Shares Price Value
Horn Howard Chief Financial Officer
Oct 15, 2026
S-Sale Common Stock
7,066 15.27 $107,898
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sep 15, 2026
S-Sale Common Stock
1,283 13.57 $17,410
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sep 3, 2026
S-Sale Common Stock
161 13.99 $2,252.39
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.